The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterationsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked how the gut microbiota changes as tuberculosis moves from latent infection to active disease. Researchers used 16S rDNA sequencing on fecal samples to compare bacterial communities across three groups. They measured alpha diversity, beta diversity, and group-specific taxa using LEfSe analysis. PICRUSt2 predicted which metabolic pathways were active in each group. The aim was to clarify the microbial links behind progression from latent to active tuberculosis.
Who was studied?
The cohort was human, comparing three groups: people with active tuberculosis, people with latent tuberculosis infection, and healthy controls. Fecal samples supplied the material for gut microbiota profiling. The research was conducted in China. Exact sample sizes and participant ages for each group were not reported. Groups were defined clinically as active disease, latent infection, or healthy status.
What were the most important findings?
Alpha diversity was lowest in active tuberculosis and highest in healthy controls, showing a stepwise loss of diversity with disease progression. Beta diversity differed significantly between every pair of groups. Latent infection was marked by probiotic genera Romboutsia, Bifidobacterium and Lactobacillus. Active tuberculosis was marked by pro-inflammatory Ruminococcus gnavus, Streptococcus and Erysipelatoclostridium. The pentose phosphate pathway was active in both infected groups and most active in active disease. Differences reached statistical significance at P below 0.05.
What are the greatest implications of this study?
The findings suggest gut bacteria may help shape whether latent tuberculosis advances to active disease. The authors propose that some intestinal microbes suppress interferon-gamma and interleukin-17, which could aid survival and spread of Mycobacterium tuberculosis. Microbial metabolites and gut dysbiosis may also influence this transition. These associations are correlational and do not establish that microbiota changes cause progression. Gut taxa could become candidate biomarkers for tuberculosis risk, pending larger validation.